Table 5.

Number of countries with significantly increasing or decreasing trends in resistance to selected antimicrobials for Campylobacter jejuni and C. coli in humans, 2016–2020

Species	Ciprofloxacin		Erythromycin		Tetracycline
	Incr.	Decr.	Incr.	Decr.	Incr.	Decr.
C. jejuni (16 MS + 3 non‐MS)	9 (DK, ES, FR, LT, MT, NL, SI, SK, UK)	4 (EE, FI, NO, PT)	–	5 (FI, LT, MT, NO, UK)	4 (DK, NL, SK, UK)	6 (CY, EE, FI, LT, NO, PT)
C. coli (14 MSs + 1 non‐MS)	1 (SI)	4 (FR, LU, PT, UK)	2 (FI, NL)	2 (EE, SK)	–	–